Medical marijuana was and is opening the door for a reconsideration of cannabis’ place in polite society. In time, cannabis will work through to the government admitting and apologizing for the lies of the past 80 years. But, don’t hold your breath on that one. MMJ will be a fact everywhere before the day of contrition arrives. We are, however, still moving in the right direction. Here’s this week’s MMJ update, traveling East-to-West.
New Hampshire: Democrat Gov. Maggie Hassan has signed legislation expanding the list of qualifying conditions for which a physician may recommend marijuana therapy. House Bill 476 adds epilepsy, lupus and Parkinson’s disease to the list of state-qualifying conditions. The new law goes into effect in early September. Despite its passage in 2013, New Hampshire’s medical marijuana program still remains non-operational at this time.
The NH system isn’t even up-and-running and it’s being tweaked to be up-to-date when the time comes. That’s good, and we find the same experience in…
Delaware: Democrat Gov. Jack Markell has signed legislation, Senate Bill 90, into law expanding the state’s nascent medical marijuana law. The measure expands the list of qualifying conditions for which a physician may recommend medical cannabis to include intractable epilepsy. The measure also creates a patient registry for those under the age of 18.
Let’s move west to…
California: One type of discrimination is being addressed. “Democrat Gov. Jerry Brown signed legislation, Assembly Bill 258, to allow medical marijuana patients to be considered to receive organ transplants.
Hospitals in California and elsewhere have denied patients from receiving organ transplants solely based on their status as medicinal marijuana consumers. Assembly Bill 258 reads, ‘A hospital, physician and surgeon, procurement organization, or other person shall not determine the ultimate recipient of an anatomical gift based solely upon a potential recipient’s status as a qualified patient, as defined in Section 711362.7, or based solely upon a positive test for the use of medical marijuana by a potential recipient who is a qualified patient.'”
The new law takes effect on January 1, 2016.
Finally, let’s check in with our favorite federal goverment. This one’s a hoot. The federal government, who for years has thwarted legitimate invistigation into cannabis, now asks for more producrers of research cannabis — to do legitimate investigations. Has the tide turned, or what?
The National Institute on Drug Abuse Director (NIDA) Nora Volkow told a Congressional committee that the agency’s monopoly on the federally licensed production of marijuana for clinical research is problematic and ought to be amended to include additional producers.
Speaking late last month at a hearing before the U.S. Senate Caucus on International Narcotics Control, Dr. Volkow acknowledged, “It would be beneficial” for the federal government to allow private entities to produce cannabis for clinical research purposes.
. . .
An additional regulatory requirement mandating that the U.S. Public Health Service review all clinical protocols was abolished last month.
Find more information on each story at the original source HERE.
I bet a fair number of growers would donate some of the harvest for legitimate research. Cannabis is not afraid of a fair trial on a level playing field. The cannabis plant will win that challenge.
[Image via: Google images “medical marijuana”]
Featured Partner: Meet All Your Local Marijuana Needs (Buy Sell Buds) Anonymously In Real-Time For FREE
Leafedin – Weed App – Find Weed Near You! Meet Any of Your Marijuana Product or Labor Needs Locally in Real-Time! Free Anonymous Map Weed App, Works On Any Device, Sign-Up In Seconds and Find Bud Connects Marijuana Work or Labor, New Clients, etc INSTANTLY!